Schmidt, B; Anderson, P J; Doyle, L W; Dewey, D; Grunau, R E; Asztalos, E V; Davis, P G; Tin, W; Moddemann, D; Solimano, A; Ohlsson, A; Barrington, K J; Roberts, R (2012). Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA : the Journal of the American Medical Association, 307(3):275-282.
Dukhovny, D; Lorch, S A; Schmidt, B; Doyle, L W; Kok, J H; Roberts, R S; Kamholz, K L; Wang, N; Mao, W; Zupancic, J A F (2011). Economic evaluation of caffeine for apnea of prematurity. Pediatrics, 127(1):e146-e155.
Davis, P G; Schmidt, B; Roberts, R S; Doyle, L W; Asztalos, E; Haslam, R; Sinha, S; Tin, W (2010). Caffeine for apnea of prematurity trial: benefits may vary in subgroups. Journal of Pediatrics, 156(3):382-387.